44.81

1.08% -0.49

After Hours: 44.72 -0.09 -0.20%

Boston Scientific Corp (BSX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Boston Scientific Corp stock is traded at $44.81, with a volume of 13.51M. It is down -1.08% in the last 24 hours and down -7.99% over the past month. Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Previous Close:

$45.30

Open:

$44.7

24h Volume:

13.51M

Relative Volume:

0.67

Market Cap:

$66.60B

Revenue:

$20.62B

Net Income/Loss:

$3.56B

P/E Ratio:

18.79

EPS:

2.3847

Net Cash Flow:

$3.48B

1W Performance:

+4.06%

1M Performance:

-7.99%

6M Performance:

-54.45%

1Y Performance:

-56.24%

1-Day Range:

$44.01

$44.98

1-Week Range:

$43.45

$46.37

52-Week Range:

$42.25

$109.50

Boston Scientific Corp Stock (BSX) Company Profile

Name

Boston Scientific Corp

Sector

Healthcare (1094)

Industry

Medical Devices (142)

Phone

508-683-4000

Address

300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA

Employee

59,000

Twitter

@bostonsci

Next Earnings Date

2026-07-29

Latest SEC Filings

BSX's Discussions on Twitter

Compare BSX vs ABT, SYK, MDT, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BSX Boston Scientific Corp	44.81	67.33B	20.62B	3.56B	3.48B	2.3847
ABT Abbott Laboratories	95.18	166.94B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	326.85	126.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	82.01	107.31B	36.36B	4.84B	5.43B	3.7212
EW Edwards Lifesciences Corp	93.64	54.60B	6.30B	1.07B	1.09B	1.8406

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-30-26	Downgrade	Raymond James	Strong Buy → Outperform
Oct-03-25	Downgrade	Erste Group	Buy → Hold
Sep-08-25	Upgrade	Oppenheimer	Perform → Outperform
Jun-16-25	Initiated	Leerink Partners	Outperform
Apr-16-25	Upgrade	Needham	Hold → Buy
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy
Feb-01-24	Upgrade	Mizuho	Neutral → Buy
Jul-19-23	Initiated	Robert W. Baird	Outperform
Jun-30-23	Initiated	CL King	Buy
May-30-23	Resumed	Morgan Stanley	Overweight
Mar-29-23	Initiated	UBS	Buy
Dec-22-22	Initiated	Mizuho	Neutral
Dec-20-22	Resumed	Citigroup	Buy
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Jul-06-22	Initiated	Wolfe Research	Outperform
May-27-22	Upgrade	Needham	Hold → Buy
Apr-13-22	Resumed	Truist	Buy
Mar-02-22	Resumed	BofA Securities	Buy
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
May-26-21	Downgrade	Needham	Buy → Hold
May-25-21	Initiated	Barclays	Overweight
Apr-15-21	Initiated	Atlantic Equities	Overweight
Sep-17-20	Initiated	Truist	Buy
Sep-11-20	Initiated	Wolfe Research	Peer Perform
Apr-22-20	Downgrade	SVB Leerink	Outperform → Mkt Perform
Apr-01-20	Upgrade	Goldman	Neutral → Buy
Mar-05-20	Initiated	Citigroup	Buy
Feb-13-20	Initiated	Goldman	Neutral
Feb-06-20	Resumed	BTIG Research	Buy
Dec-30-19	Reiterated	Cowen	Outperform
Dec-19-19	Downgrade	Needham	Strong Buy → Buy
Sep-05-19	Resumed	JP Morgan	Overweight
Sep-03-19	Resumed	Barclays	Overweight
May-13-19	Upgrade	Evercore ISI	In-line → Outperform
Nov-28-18	Initiated	UBS	Buy
Oct-16-18	Initiated	Barclays	Overweight
Oct-02-18	Reiterated	Morgan Stanley	Overweight
Sep-07-18	Reiterated	Needham	Strong Buy
Sep-04-18	Upgrade	Jefferies	Hold → Buy
Jul-06-18	Reiterated	Needham	Strong Buy
Jun-27-18	Initiated	Bernstein	Outperform
Apr-26-18	Reiterated	Needham	Strong Buy

View All

Boston Scientific Corp Stock (BSX) Latest News

05:33 AM

Boston Scientific (NYSE:BSX) Climbs As Cardiology Demand Expands - Kalkine Media

05:33 AM

12:52 PM

BSX Maintained by Needham -- Price Target Lowered to $57.00 - GuruFocus

12:52 PM

07:11 AM

Needham cuts Boston Scientific stock price target on WATCHMAN sales By Investing.com - Investing.com Canada

07:11 AM

Jul 07, 2026

Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch

Jul 07, 2026

Boston Scientific focuses on cardiovascular innovation as medical device demand grows - AD HOC NEWS

Jul 07, 2026

Jul 06, 2026

Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts - Yahoo Finance

Jul 06, 2026

Boston Scientific Corp. stock underperforms Monday when compared to competitors - MarketWatch

Jul 06, 2026

Is Boston Scientific (BSX) Still One of the Best Stocks to Invest In After Jefferies Slashed Its Target? - Yahoo Finance

Jul 06, 2026

BSXBoston Scientific Corp Volatility & Greeks - Finviz

Jul 06, 2026

Boston Scientific (BSX) Stock Could Be A Bargain After A 57% Slump - Yahoo Finance

Jul 06, 2026

Boston Scientific: The Time Has Come To Catch This Falling Knife (NYSE:BSX) - Seeking Alpha

Jul 06, 2026

Munro Partners's Boston Scientific Corp(BSX) Holding History - GuruFocus

Jul 06, 2026

Boston Scientific Corp. highlights minimally invasive care. Long-term demand supports its medical te - AD HOC NEWS

Jul 06, 2026

Boston Scientific Corp (NYSE:BSX) Offers Strong Value with High Profitability and Solid Growth - ChartMill

Jul 06, 2026

Jul 05, 2026